EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intravenous nalbuphine for prevention of intrathecal morphine-induced nausea and vomiting in post caesarean section

Preeyaphan Arunakul, Noppasorn Vissanuwong, Niruji Saengsomsoun, Jedsadayoot Sakaroonchai

F1000Research · 08.10.2026 · 15 · 1689

DOI: 10.12688/f1000research.181584.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, online erschienen am 08.10.2026. Verfasst von Preeyaphan Arunakul und 3 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thammasat University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postoperative nausea vomiting (PONV) is quite common among patients who underwent cesarean section under spinal anesthesia with intrathecal morphine (ITMO). Nalbuphine is a mu receptor antagonist and kappa receptor agonist, which may mitigate opioid-related side effects. We hypothesized that intravenous (IV) nalbuphine administration could possibly reduce the incidence of PONV.

Methods

In this randomized controlled trial, every patient receives spinal anesthesia with 0.2 mg of morphine for cesarean section. After umbilical cord clamping, patients in the study group received a single dose of 4 mg of IV nalbuphine. The primary outcome was the incidence of PONV in the first 24 hours. Secondary outcomes were the severity of nausea and vomiting, pain scores, incidence of pruritus and respiratory depression.

Results

One hundred and sixty-seven patients were included in the study. In 24 hours, incidence of nausea and vomiting in the nalbuphine group was lower than the placebo groups (23.81% and 42.17%). Ten percents of patients in the nalbuphine group had nausea and vomiting required treatment in the first 6 hours compared to 14.45% in the placebo group. Number of patients with pruritus and number of patients required rescue analgesic were also lower in nalbuphine group. No respiratory depression was observed in this study.

Conclusion

Four mg of IV nalbuphine could lower the incidence of PONV 24 hours after spinal anesthesia with 0.2 mg ITMO in patients underwent cesarean section. Incidence of other adverse effects also seem to be lower in the nalbuphine group.

Förderung

  • Thammasat University

Zitieren

APA

Arunakul, P., Vissanuwong, N., Saengsomsoun, N., & Sakaroonchai, J. (2026). Intravenous nalbuphine for prevention of intrathecal morphine-induced nausea and vomiting in post caesarean section. F1000Research, 15, 1689. https://doi.org/10.12688/f1000research.181584.1

Vancouver

Arunakul P, Vissanuwong N, Saengsomsoun N, Sakaroonchai J. Intravenous nalbuphine for prevention of intrathecal morphine-induced nausea and vomiting in post caesarean section. F1000Research. 2026;15:1689. doi:10.12688/f1000research.181584.1

BibTeX
@article{Arunakul2026,
  author = {Arunakul, Preeyaphan and Vissanuwong, Noppasorn and Saengsomsoun, Niruji and Sakaroonchai, Jedsadayoot},
  title = {Intravenous nalbuphine for prevention of intrathecal morphine-induced nausea and vomiting in post caesarean section},
  journal = {F1000Research},
  year = {2026},
  volume = {15},
  pages = {1689},
  doi = {10.12688/f1000research.181584.1}
}
Kostenlos starten →